Virologic response to efavirenz-based first-line antiretroviral therapy in children with previous exposure to antiretrovirals to prevent mother-to-child transmission

Efavirenz-based first-line regimens have been widely used for children ≥3 years of age starting antiretroviral therapy, despite possible resistance with prior exposure to non-nucleoside reverse transcriptase inhibitors for prevention of mother-to-child transmission (PMTCT). We used logistic regressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nyakato, Patience, Davies, Mary-Ann, Technau, Karl-Gunter, Fatti, Geoffrey, Rabie, Helena, Tanser, Frank, Boulle, Andrew, Wood, Robin, Eley, Brian, Sawry, Shobna, Giddy, Janet, Sipambo, Nosisa, Kuhn, Louise, Fairlie, Lee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259572/
https://www.ncbi.nlm.nih.gov/pubmed/32469985
http://dx.doi.org/10.1371/journal.pone.0233693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259572/
https://www.ncbi.nlm.nih.gov/pubmed/32469985
http://dx.doi.org/10.1371/journal.pone.0233693

Ejemplares similares